Aethlon Medical (AEMD) Earnings Date & Reports

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

AEMD is expected to report earnings to fall 118.47% to -75 cents per share on August 19

Aethlon Medical AEMD Stock Earnings Reports

Q2'26

Est.

$-0.75

Q1'26

Beat

by $4.99

Q4'25

Missed

by $1.33

Q3'25

Missed

by $2.66

Q2'25

Beat

by $0.24

The last earnings report on June 10 showed earnings per share of $4.08, beating the estimate of -91 cents. With 27.43K shares outstanding, the current market capitalization sits at 1.48M.

View a ticker or compare two or three

AEMD

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days